semaglutide con l carnitine + L-Carnitine PRODUCTS | CITIZEN MEDS

This is where bioavailability becomes the most important factor

Hypothetical Conservative Combination Protocol A conservative approach to combining these peptides would likely involve: Phase 1: Tirzepatide Establishment (Weeks 1-12) Week 1-4: Tirzepatide 2.5 mg weekly Week 5-8: Tirzepatide 5 mg weekly Week 9-12: Tirzepatide 7.5 mg weekly Cagrilintide: None (establish baseline tolerance) Phase 2: Cagrilintide Introduction (Weeks 13-20) Week 13-16: Tirzepatide 7.5 mg + Cagrilintide 0.6 mg weekly Week 17-20: Tirzepatide 7.5 mg + Cagrilintide 1.2 mg weekly Phase 3: Optimization (Week 21+) Tirzepatide 10-12.5 mg + Cagrilintide 2.4 mg weekly Adjust based on tolerance and response "The key principle when considering any peptide combination is sequential introduction with careful monitoring of tolerability markers, particularly gastrointestinal symptoms that could compound across mechanisms." This theoretical framework prioritizes safety through staged introduction, though actual clinical protocols would require medical supervision and monitoring

Your first visit includes an 80+ biomarker panel and an InBody 770 body composition scan

Epithalon therapy may be appropriate for individuals who are: Interested in proactive, preventive approaches to aging Experiencing age-related decline in energy, sleep quality, or cognitive function Looking to complement other longevity treatments Seeking evidence-based anti-aging interventions Adults over 30 who want to optimize their cellular health As with all treatments at Recover Restore Revive, Epithalon therapy begins with a comprehensive consultation to determine if its the right fit for your health goals

Article from medscape.com

Its an understandable question given the rapid, almost dizzying pace of innovation in metabolic peptide research